NPPA Fixes Ceiling Prices for 928 Scheduled Formulations

The National Pharmaceutical Pricing Authority (NPPA) under the Ministry of Chemicals and Fertilizers, has fixed the ceiling prices of 928 scheduled drug formulations as of 25th March 2025. This critical announcement aligns with the provisions of the Drugs (Prices Control) Order, 2013 (DPCO, 2013) and serves as a reaffirmation of the government’s commitment to ensuring essential medicines remain accessible and affordable to the public.

Key Highlights of the Announcement:

Ceiling Prices Fixed for 928 Drugs: As of 25.03.2025, NPPA has revised and fixed ceiling prices for 928 scheduled drug formulations under DPCO, 2013.
Annual Price Revision Linked to WPI: In accordance with DPCO provisions, the ceiling prices of scheduled medicines are revised annually based on the Wholesale Price Index (WPI) for all commodities. For FY 2024-25, the prices were increased by 0.00551%, effective 1st April 2024.
Retail Prices of New Drugs: NPPA also continues to monitor the pricing of new drugs under paragraph 2(1)(u) of DPCO, 2013. As of 25.03.2025, the authority has notified around 3,200 retail prices under this category.
Transparency through Public Access: All updated and revised price notifications are publicly accessible on NPPA’s official website: www.nppaindia.nic.in, ensuring transparency and easy reference for stakeholders.

Why This Matters:

The DPCO empowers the NPPA to fix and regulate the prices of medicines to ensure that the cost burden on patients is minimized. The recent updates come as a significant move amidst rising healthcare costs, aiming to bring economic relief to millions of Indian households relying on prescription medications.

Government Statement:

The Union Minister of State for Chemicals and Fertilizers, in a written reply during a Lok Sabha session. Her statement underscored the government’s steadfast efforts in maintaining price discipline in the pharmaceutical sector.

Looking Ahead:

With over 3,200 new drug prices notified and nearly a thousand formulations under pricing regulation, NPPA continues to play a pivotal role in India’s healthcare ecosystem. These efforts support broader national goals such as Universal Health Coverage (UHC), health equity, and the right to affordable healthcare for all.

As India strengthens its position as a global pharmaceutical hub, initiatives like this reinforce the importance of balancing innovation, accessibility, and affordability in public health policy.

Listen to this on our #YouTube Channel

In case you face any issues related to Indirect Tax-Customs, GST, Foreign Trade Policy (FTP), Arbitration matters and Central Licensing and related advisory matters in India then please feel free to get in touch with SJ EXIM Services.

We offer Legal advice and litigation support in matters related to Indirect Tax-Customs, FTP, other Indirect Tax matters & Arbitration law, all sorts of Central licensing and related matters. Come and explore the new way of doing business with us!

Source: PIB, Govt of India

PIB Press ReleaseDownload

Connect with us for more-

@ Team S J EXIM SERVICES, New Delhi, IN

CP: Ms. Shubhra Jha, Founder

Tel: +91-11-4999 2707 I +91-9999005693

Web: www.sjexim.services

EMAIL: operations@sjexim.services I shubhra@sjexim.services

Facebook: www.facebook.com/sjeximservices

LinkedIn: https://www.linkedin.com/company/90794255/admin/feed/posts/

YouTube: https://www.youtube.com/@sjeximIndia

Subscribe our WhatsApp Channel: https://whatsapp.com/channel/0029VaTxDT8JZg4CHEOSoK47

Subscribe our Telegram Channel: https://t.me/sjeximindia

Disclaimer:

1. The views expressed are based on the interpretation of the relevant information/documents, applicable law, and government policy and there is no assurance that a court or tribunal or regulatory body or other governmental authority may not interpret it differently.

2. We are not responsible for updating or revising this article on account of any change in law or interpretation thereof or a change in events or circumstances informed or occurring after the date of this article unless specifically requested for it.

3. Our advice should not be taken or used out of context or reproduced for any other purpose or transaction. Views expressed in this update are strictly personal, based on our understanding of the underlying law.

4. We are not responsible for any injury, loss or cost arising to any person who refers to this update and acts or refrains from any act accordingly. We would suggest that detailed legal advice must be sought before relying on this update.

NOTE: All Inquiries/Consulting/Advisory/Assignments are solicited via email only & it is a PAID Service only!

#LawFirm #Lawyers #Arbitration #ArbitrationLaw #ADR #India #Law #LegalUpdates #NewDelhi #IndirectTax #IndirectTaxLaw #CBIC #FTP #CommercialLaw #CorporateLaw #ConstitutionalLaw #BarandBench #InternationalArbitration #InternationalCommercialArbitration #WTO #TBT #QCO #BIS #UnitedNations #UNO #DutyDrawback #CustomsAct #Advisory #ProBonoConsulting #IndiaCustomsAtWork #Facebook #Twitter #Instagram #LinkedIn #Tumblr #WhatsAppChannel #WhatsApp #YouTubeChannel #YouTube #KPMG #Deloitte #ErnstandYoung #GrantThornton #EY #PWC #BDO #Consulting #SettlementCase #DGFT #CII #FICCI #IndianChamberofCommerce #InternationalChamberofCommerce #PHDChamberofCommerce #FTP #FTP2023 #Compliance #CDSCO #HighCourts #SupremeCourt #DPIIT #CESTAT #CAAR #AdvanceRuling #CEX #Appeal #Refunds #IGSTRefund #Google #GoogleSearch #GoogleSEO #AIFTA #FTA #ASEAN #CustomsAdvanceRuling #JICA #JETROIndia #KITAIndia #KOTRAIndia #Multinationalcompanies #JapaninIndia #KoreainIndia #GovtofIndia #MinistryofcommerceIndia #TradeDeals #FTA #RulesofOrigin #SJEXIMServices #NewDelhi #India #Ministryofsteel #SteelQCO

S J EXIM Services